TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

Bowel Diseases, Inflammatory Clinical Trial

Official title:
A 2-Cohort Study to Evaluate the Absolute Bioavailability, Absorption, Distribution, Metabolism and Excretion of TD-1473 Following an Intravenous and an Oral Dose of [14C]-TD-1473 in Healthy Male Subjects

Status Completed

Clinical Trial Summary

This is an open-label, 2-cohort study to evaluate the absolute bioavailability, absorption, distribution, metabolism and excretion of TD-1473 in healthy male subjects. Subjects in cohort 1 will receive a single oral dose of TD-1473 and a single intravenous bolus dose of [14C]-TD-1473. Subjects in cohort 2 will receive a single oral dose of [14C]-TD-1473 only.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03408470
Study type	Interventional
Source	Theravance Biopharma
Contact
Status	Completed
Phase	Phase 1
Start date	January 31, 2018
Completion date	February 21, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00640809` - Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole	Phase 4
Completed	`NCT04587713` - Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects	Phase 1
Completed	`NCT05043363` - LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19
Completed	`NCT02799615` - Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Not yet recruiting	`NCT02760940` - Anemia in Inflammatory Bowel Disease	Phase 4
Terminated	`NCT04032756` - Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Terminated	`NCT02255227` - Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD	Phase 2
Completed	`NCT03999294` - Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease	N/A